Catalyst Wire Dossier Catalyst Wire Dossier

Tepezia

Teprotumumab · Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tepezia, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients

See pricing